Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Apollo Hospitals Enterprise announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: Q2FY25 Revenues grew to Rs 5,589 crore; 15% YoY growth Healthcare Services (HCS) Revenue at Rs 2,903 Crore; 14% YoY growth AHLL: Revenues at Rs 404 crore; 14% YoY growth Apollo HealthCo: Pharmacy Distribution & Digital Health Revenues at Rs 2,282 crore; 17% YoY growth GMV of Apollo 24/7 at Rs 757 crore. Q2FY25 Consolidated EBITDA stood at Rs 816 crore; 30% YoY growth Healthcare Services (HCS) EBITDA at Rs 722 crore; YoY growth of 14% AHLL EBITDA at Rs 41 crore; YoY growth of 30% Apollo HealthCo: Pharmacy distribution & Digital health EBITDA at Rs 52 crore Q2FY25 Consolidated PAT Rs 379 crore, compared to Rs 233 crore in Q2 FY24; 63% YoY growth Healthcare Services (HCS) PAT at Rs 364 Crore; YoY growth of 16%. H1FY25 Financial Highlights: H1FY25 Revenues grew to Rs 10,675 crore; 15% YoY growth Healthcare Services (HCS) Revenue at Rs 5,541 crore; 14% YoY growth AHLL: Revenues at Rs 770 crore; 14% YoY growth Apollo HealthCo: Pharmacy Distribution & Digital Health Revenues at Rs 4,364 crore;16% YoY growth GMV of Apollo 24/7 at Rs 1,452 crore H1FY25 Consolidated EBITDA stood at Rs 1,491 crore; 31% YoY growth Healthcare Services (HCS) EBITDA at Rs 1,344 crore; YoY growth of 14% AHLL EBITDA at Rs 72 crore; YoY growth of 31% Apollo HealthCo: Pharmacy distribution & Digital health EBITDA at Rs 75 crore H1 FY25 Consolidated PAT Rs 684 crore, compared to Rs 400 crore in H1 FY24; 71% YoY growth Healthcare Services (HCS) PAT at Rs 693 Crore; YoY growth of 20% Prathap C Reddy, Founder & Chairman, Apollo Hospitals Group said: "Apollo Hospitals, we are dedicated to continually evolving to meet the changing healthcare needs of our nation. Through strategic initiatives like our investment in Apollo Health and Lifestyle and the launch of new multi-specialty hospitals, we reaffirm our commitment. to expand access to high-quality healthcare across India, particularly in regions where critical care access is essential. One of our proudest achievements is our recent partnership with the Government of Tripura to provide free heart surgeries for children, underscoring our belief that healthcare should reach those who need it most, especially in underserved communities. Beyond expanding access, we are advancing medical technology with innovative treatments like water vapor thermotherapy for prostate care and robotic radiosurgery systems for cancer. These state-of-the-art solutions make procedures less invasive and reduce recovery time, resulting in better patient outcomes. We're also investing in the future of healthcare with the launch of our new research academy, which is focused on driving groundbreaking medical discoveries that will shape the next generation of treatments. Our priorities remain clear-enhancing patient care, prioritizing safety, and advancing medical science. The first half of FY25 has been an exciting time for us, marked by these major milestones aimed at extending the reach and impact of our healthcare services. Moving forward, our mission is simple: to push the boundaries of healthcare and ensure that everyone, regardless of where they live, has access to the best medical services. This is our promise, and we are committed to making it a reality." Result PDF